Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

29
Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center

Transcript of Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

Page 1: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

Immunophenotyping Intimal Arteritis

Anthony Chang, MD

University of Chicago Medical Center

Page 2: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

Immunophenotyping intimal arteritis

• Is there a difference in the immunophenotype of lymphocytes in the setting of intimal arteritis associated with T cell-mediated rejection (TCMR) versus antibody-mediated rejection (AMR)?

Page 3: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

Literature Review• Intimal arteritis immunophenotype studies

– Tuazon TV et al. Am J Pathol 1987• CD8, CD4

– Alpers C, et al. Mod Pathol 1990• CD45, UCHL-1 (CD45RO or memory T cells)• L-26 (CD20+ B cells)• HAM-56 (macrophages, endothelium)• Leu-M1 (CD15 granulocytes), Factor VIII and

Ulex uropaeus (endothelium), HHF-35 (smooth muscle actin), S100 (DCs, some macrophages)

• 22 cases

Page 4: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

Literature Review

• Intimal arteritis immunophenotype studies– Matheson P, et al. Transplantation 2005

• UCHL-1 (CD45RO T cells)• CD68 (macrophages)• 8 of 24 bxs with type II or III rejection• CD68 > UCHL-1

– Kozakowski N, et al. NDT 2009• CD68/CD3 ratio in 116 arteries from 34 patients

– Did not correlate with C4d– Did not correlate with worse graft survival

Page 5: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

Literature Review

• Intimal arteritis immunophenotype studies– Sementilli A, et al. Tx Proceedings 2010

• CD68, CD4/CD8, CD20, S100• IL-4, IL-10, interferon-gamma• 10 of 40 bxs with type II rejection• CD8 > CD68

Page 6: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

Immunophenotyping intimal arteritis

• Is immunophenotype of lymphocytes in the setting of intimal arteritis associated with T cell-mediated rejection (TCMR) different from the lymphocytes associated with antibody-mediated rejection (AMR)?

Page 7: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

Our study

• Intimal arteritis/endarteritis lesions– U of Chicago Med Ctr (n=20) – Cedar Sinai Med Ctr (n=12)

• 15 – AMR only, 11 – TCMR+AMR, 6 – TCMR only

• Immunohistochemistry– CD3, CD8, CD4, Foxp3– CD20– CD68 and CD163– CD56

Page 8: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD3+ T cells

Page 9: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD3+ T cells

Page 10: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD8+ T cells

Page 11: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

Tregs (CD4+/foxp3+)

1 of 13 cases

Page 12: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

Tregs (CD4+/foxp3+)

Page 13: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD68

Page 14: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD163

• Scavenger receptor

• Limited to macrophage/monocyte lineage

Page 15: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD163

Page 16: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD163

Page 17: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD68 / CD163

CD68 CD163

Page 18: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD20+ B cells

Page 19: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD20+ B cells

Page 20: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD20+ B cells

• 5 of 29 cases with any CD20+ B cells– 2 with isolated v lesions and C4d+

• 1 DSA+ class II, 1 DSA+ class I+II

– 1 with isolated v lesion• C4d+ 5% of ptc, DSA/PRA-not tested

– 1 with TCMR and AMR• C4d+ 5-10% of ptc, high PRA class I/II, DSA-

– 1 isolated v lesion• C4d-, PRA/DSA-

– 15 isolated v lesions with AMR only

Page 21: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.
Page 22: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD56

Page 23: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD56 (NCAM)

Page 24: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD56 (NCAM)

Page 25: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD56

Page 26: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD56

Page 27: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

CD56 (NCAM)• 9 CD56+ cases

– No more than 4 CD56+ NK cell present– 2 cases with CD56 granular staining only; no

CD56+ lymphocytes

• Of 9 isolated v lesions– 7 with either CD56+ cell (n=5) or granular

staining (n=2)

• 7 of 10 CD56 staining with AMR alone• 0 of 2 CD56 staining in TCMR alone• 2 of 10 CD56 staining in TCMR+AMR

Page 28: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

Summary

• CD56 may be a useful marker to distinguish intimal arteritis associated with AMR from TCMR– Additional studies

• CD20 – infrequent

• CD3, CD8, CD68, CD163 – no significant difference

Page 29: Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.

Acknowledgement

• Collaborators– Mark Haas, Cedars Sinai Medical Center